Grape Seed Extract for Peripheral Circulation

Verdict: Weak, mostly subjective evidence for circulation

Grape seed extract shows only weak, low-certainty evidence for peripheral circulation: small trials hint at relief of subjective vein-related leg symptoms (heaviness, swelling, reflux), but the objective measure of blood-vessel function was unchanged, so it should not be relied on to improve circulation.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The clinical signal is limited to subjective venous symptoms and rests on small, low-quality studies. The 2026 open-label VICTORY trial (PMID 41242464, n=176, 300 mg/day for 12 weeks) reported less venous reflux and better symptom and quality-of-life scores, but with no placebo arm its results are highly vulnerable to placebo and detection bias. A 23-patient pilot using 4D-flow MRI (PMID 36401399) saw faster vena-cava flow in the extract arm but ran no between-group statistical test, and an industry-funded crossover trial (PMID 22752876) reduced leg swelling during prolonged sitting in healthy women.

Crucially, the best objective vascular endpoint is negative. A 19-trial meta-analysis (PMID 34798267) found no significant effect on flow-mediated dilation (WMD +1.02%, 95% CI -0.62 to 2.66), undercutting any claim that grape seed extract genuinely improves blood-vessel function, even though it modestly lowered diastolic blood pressure and heart rate.

Regulators and clinicians do not endorse it for circulation. EFSA rejected the OPC chronic-venous-insufficiency health claim in 2010, and the US FDA has treated disease-treatment claims for OPC products as illegal drug claims. Mayo Clinic lists no grape seed page, and vascular guidelines favor supervised exercise, risk-factor control and agents like horse chestnut, not grape seed extract. The honest verdict is a weak, preliminary signal on vein symptoms, not proven help for circulation.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.48
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
80%
Broadly consistent
Evidence level
E3
Single high-quality meta-analysis

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.55
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.485
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Vitis vinifera seed extract reduces venous reflux time in patients with varicose veins: VICTORY randomized controlled trial
PMID: 41242464 2026 RCT (open-label) n = 176
Finding: The grape seed extract group showed significantly greater reduction in mean venous reflux time in both superficial and deep veins, a higher proportion reaching clinically meaningful reflux thresholds, and superior improvement in Venous Clinical Severity Score and quality-of-life scores; benefits were consistent across subgroups.
🟠 Limited quality Effect size: Greater venous reflux time reduction vs control (open-label, no placebo); magnitude not extractable from abstract
View on PubMed
Pilot study on the effect of grape seed proanthocyanidin extract on inferior vena cava blood flow in patients with chronic venous insufficiency using 4D flow MRI
PMID: 36401399 2022 Other n = 23
Finding: Peak velocity increased significantly in the stocking + GSPE group (+4.85 +/- 5.57 cm/s, P<0.001) but not in the stocking-alone group (+2.48 +/- 5.05 cm/s, P=0.16); interpreted as GSPE potentially improving venous return.
🟠 Limited quality Effect size: Within-group peak velocity change +4.85 cm/s (GSPE arm); no direct between-group statistical test reported
View on PubMed
Proanthocyanidin-rich grape seed extract reduces leg swelling in healthy women during prolonged sitting
PMID: 22752876 2013 RCT (double-blind)
Finding: Leg volume distension, increase in body extracellular fluid and leg water were significantly suppressed in the grape seed extract groups versus placebo; concluded GSE intake inhibits leg swelling during prolonged sitting in healthy women.
🟠 Limited quality ⚠️ Industry-funded Effect size: Significant suppression of leg volume distension vs placebo; absolute magnitude not in abstract
View on PubMed
The effect of grape (Vitis vinifera) seed extract supplementation on flow-mediated dilation, blood pressure, and heart rate: A systematic review and meta-analysis of controlled trials with duration…
PMID: 34798267 2022 統合分析
Finding: Grape seed extract significantly reduced DBP (WMD -2.20 mmHg, 95% CI -3.79 to -0.60) and heart rate (WMD -1.25 bpm, 95% CI -2.32 to -0.19), but had NO significant effect on flow-mediated dilation (WMD 1.02%, 95% CI -0.62 to 2.66) or SBP (WMD -3.55 mmHg, 95% CI -7.59 to 0.49).
Mixed funding Effect size: FMD WMD +1.02% (NS); DBP WMD -2.20 mmHg; HR WMD -1.25 bpm
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
OPCs also act as a natural histamine and can be helpful treating allergies, asthma, bronchitis, arthritis, muscle tissue injuries and ulcers source↗
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Neutral
葡萄(學名:Vitis vinifera L.)之種子及果皮可供食品使用,其所含前(原)花青素(proanthocyanidin)每日最高攝食量為 150 毫克。 source↗
L5a NIH Office of Dietary Supplements
Cautious
L5c Cleveland Clinic
Neutral
L5e Specialty Society (condition-mapped)
Not addressed
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-peripheral-circulation-INT-grape-seed-extract-001 繁體中文版 →